Company / Revenue
RHYTHM PHARMACEUTICALS, INC. Revenue History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Revenue
$189.8M
FY2025
5-year range
$3.2M / $189.8M
FY2021-FY2025
Trend
+45.8%
vs FY2024
Sector context
#90 of 155
Health Care
What the data says
At $190M, RHYTHM PHARMACEUTICALS, INC.'s revenue ranks #90 of 155 in the Health Care sector. Revenue has increased for 5 consecutive years, from $0 in FY2018 to $190M in FY2025.
Based on SEC 10-K filings.
$190M in FY2025 with a 3-year CAGR of +100.2%.
Improved from $77M to $190M over the past 2 years.
Health Care sector context is included.
Revenue over time
Growth rates
- 3-Year CAGR
- +100.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#90 of 155 in Health CareTop 58% of 155This company $189.8M Sector average $4.5B
▼
-95.8% below sector average
Key checks
Key Insights
- RHYTHM PHARMACEUTICALS, INC.'s revenue has grown for 4 consecutive years.
- 3-year CAGR of +100.2%, indicating consistent growth.
- In FY2025, revenue increased 45.8% year-over-year.
- Ranks #90 out of 155 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.52 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | RevenueValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $189.8M | +45.8% |
| FY2024 | $130.1M | +68.1% |
| FY2023 | $77.4M | +227.6% |
| FY2022 | $23.6M | +649.5% |
| FY2021 | $3.2M | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | $0 | - |
| FY2017 | $0 | - |
| FY2016 | $0 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026